Antonella Bruzzese Selected Research

Antonella Bruzzese Research Topics

9	Multiple Myeloma 03/2024 - 01/2022
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2020
3	Hematologic Neoplasms (Hematological Malignancy) 09/2020 - 01/2019
2	Neoplasms (Cancer) 05/2024 - 10/2023
2	Anemia 04/2024 - 10/2023
2	Disease Progression 01/2024 - 10/2023
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2023 - 01/2023
2	Thrombotic Thrombocytopenic Purpura 07/2023 - 04/2023
2	Thrombosis (Thrombus) 09/2020 - 04/2020
1	Primary Myelofibrosis (Myelosclerosis) 04/2024
1	Leukemia 01/2024
1	Thrombotic Microangiopathies 07/2023
1	COVID-19 07/2023
1	Iron Overload 05/2023
1	Hyperplasia 05/2023
1	Infections 10/2020
1	Pulmonary Alveolar Proteinosis 10/2020
1	Sepsis (Septicemia) 09/2020
1	Thrombocytopenia (Thrombopenia) 04/2020
1	Venous Thromboembolism 09/2019
1	Thrombophilia 09/2019

6	Lenalidomide (CC 5013)FDA Link 01/2024 - 01/2022
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2022
5	elotuzumabIBA 01/2023 - 01/2022
3	carfilzomibIBA 12/2022 - 01/2022
2	Proteasome InhibitorsIBA 10/2023 - 01/2023
2	thiamine triphosphorate (TTP)IBA 07/2023 - 04/2023
2	caplacizumabIBA 07/2023 - 04/2023
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2020 - 09/2019
1	fms-Like Tyrosine Kinase 3IBA 05/2024
1	CytokinesIBA 04/2024
1	Janus Kinase InhibitorsIBA 04/2024
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2024
1	selinexorIBA 03/2024
1	tagraxofuspIBA 10/2023
1	Immunomodulating AgentsIBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	luspaterceptIBA 10/2023
1	ivosidenibIBA 09/2023
1	zanubrutinibIBA 09/2023
1	glasdegibIBA 09/2023
1	belantamab mafodotinIBA 05/2023
1	IronIBA 05/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2023
1	Chelating AgentsIBA 05/2023
1	Deferasirox FDA Link 05/2023
1	DeferiproneIBA 05/2023
1	acalabrutinibIBA 01/2023
1	venetoclaxIBA 01/2023
1	pomalidomideIBA 01/2023
1	isatuximabIBA 01/2023
1	Surface-Active Agents (Surfactants)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	Fondaparinux (Arixtra)FDA Link 04/2020
1	AnticoagulantsIBA 04/2020
1	AntithrombinsIBA 09/2019

6	Therapeutics 05/2024 - 01/2019
3	Drug Therapy (Chemotherapy) 10/2023 - 09/2020
3	Salvage Therapy 12/2022 - 01/2022
3	Catheters 09/2020 - 01/2020
1	Hematopoietic Stem Cell Transplantation 10/2020
1	Central Venous Catheters 09/2020
1	Parenteral Nutrition 09/2020